Skip to content
  • 6,813 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started

Special notice

Notice of Intent to Sole Source; Qiagen LLC

36C24226Q0960

Department of Veterans Affairs, 242-Network Contract Office 02. In-Vitro Diagnostic Substance Manufacturing.

Response deadline

September 15, 2026 at 10:00 AM EDT

Closed 47 days ago. Posted August 31, 2026. Scheduled to archive September 30, 2026.

Get the next one like this from Department of Veterans Affairs by email, the day it is posted.Find my opportunities

This one closed 47 days ago

13 like it are open now in in-vitro diagnostic substance manufacturing

All 13 open in in-vitro diagnostic substance manufacturing

Description

As published on SAM.gov.

This is a notice of intent to award a sole source contract and is not a request for quotes. The Department of Veterans Affairs (DVA) Network Contracting Office NCO2, on behalf of VISN2 South Medical Centers, intends to award a Firm Fixed Price (FFP), sole source action to: Name of Contractor: QIAGEN LLC Street Address: 19300 Germantown Road City, State, Zip: Germantown, MD 20874-1415 VISN02 medical centers have a recurring requirement for US Food & Drug Administration (FDA) approved In Vitro Diagnostic (IVD), cell mediated immunity (IGRA) tests for detecting Mycobacterium infections using chemiluminescence immunoassay (CLIA) on LIAISON analyzers. Market research was conducted in accordance with FAR Part 10, reviewing the offerings and capabilities available through the current marketplace. In accordance with the Revolutionary FAR Overhaul (RFO) Part 6.103-1, it has been determined that only one source is reasonably available, QIAGEN LLC. QIAGEN is the manufacturer and sole distributor of the QuantiFERON TB Gold testing. QuantiFERON is the only test capable of meeting the salient characteristics of the requirement and providing the necessary compatibility with the Department of Veterans Affairs existing LIAISON analyzers. Market research failed to produce additional sources capable of fulfilling this requirement as a whole; No subcontracting opportunities are available for this requirement. In accordance with the Revolutionary FAR Overhaul (RFO) this notice of intent to sole source with justification to limit sources, satisfies the public posting requirements. Veterans Health Administration prohibits the use of gray market items in their Medical Centers. Gray market items are considered to be items outside of the original equipment manufacturer s intended distribution channels. This notice is not a request for quotes; however, all responsible sources may submit a capability statement which shall be considered by the Government. All capability statements must be received by no later than 10:00 AM Eastern Standard Time on September 15, 2025. Responses to be submitted to Lindsay Goldsmith, Contracting Officer at lindsay.goldsmith@va.gov. A determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.

Attachments

Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. September 1, 2026

    Special notice

    Due September 15, 2026 at 10:00 AM EDT. SAM.gov, notice 398d78a5e5a84e22a38080b016673c98

    1 revisions on SAM
    • September 1, 2026: publish, special notice

Points of contact